INM
NASDAQ · Pharmaceuticals
Inmed Pharmaceuticals Inc
$0.65
-0.05 (-6.66%)
Open$0.72
Previous Close$0.70
Day High$0.73
Day Low$0.65
52W High$7.98
52W Low$0.58
Volume—
Avg Volume22.5K
Market Cap2.15M
P/E Ratio—
EPS$-4.08
SectorPharmaceuticals
Analyst Ratings
Strong Sell
8 analysts
Price Target
+5,076.9% upside
Current
$0.65
$0.65
Target
$33.65
$33.65
$24.21
$33.65 avg
$46.15
Key Financials
| FY 2026 | FY 2025 | FY 2024 | |
|---|---|---|---|
| Revenue | 16.78M | 10.14M | 790.8K |
| Net Income | -27,715,165 | -15,069,869 | 172.0K |
| Profit Margin | -165.1% | -156.9% | 21.8% |
| EBITDA | -26,163,521 | -15,016,520 | 218.3K |
| Free Cash Flow | — | — | 109.5K |
| Rev Growth | +65.5% | +65.5% | +11.4% |
| Debt/Equity | — | — | 0.10 |
Pharmaceuticals Peers
| Symbol | Name | Price | Change | P/E | Mkt Cap |
|---|---|---|---|---|---|
| LLY | Eli Lilly and Co. | $948.45 | -2.72% | 36.1 | 913.24B |
| JNJ | Johnson & Johnson | $221.32 | -0.53% | 26.1 | 548.94B |
| MRK | Merck & Co. Inc. | $111.38 | -0.82% | 31.3 | 279.42B |
| PFE | Pfizer Inc. | $25.68 | -3.02% | 19.3 | 150.09B |
| BMY | Bristol-Myers Squibb Co | $56.16 | -0.16% | 17.0 | 120.08B |
| ZTS | Zoetis Inc | $82.83 | -5.13% | 21.5 | 57.37B |